Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrogen attached directly or indirectly to the purine ring...
Reexamination Certificate
2006-10-02
2011-11-15
Lukton, David (Department: 1654)
Organic compounds -- part of the class 532-570 series
Organic compounds
Nitrogen attached directly or indirectly to the purine ring...
C424S400000
Reexamination Certificate
active
08058433
ABSTRACT:
New crystalline forms of lopinavir are disclosed.
REFERENCES:
patent: 5914332 (1999-06-01), Sham et al.
patent: 6232333 (2001-05-01), Lipari et al.
patent: 6608198 (2003-08-01), Dickman et al.
patent: 6864369 (2005-03-01), Dickman et al.
patent: 2005/0124810 (2005-06-01), Dickman et al.
patent: 96/41813 (1996-12-01), None
patent: WO9641813 (1996-12-01), None
patent: WO9641813 (1996-12-01), None
patent: 98/57648 (1998-12-01), None
patent: WO9857648 (1998-12-01), None
patent: WO0174787 (2001-10-01), None
patent: WO0174787 (2001-10-01), None
Wilhelm, Michael J. (Journal of Molecular Structure 883-884, pp. 242-248, 2008).
Hirschmugl, C. J. (Review of Scientific Instruments 66(2, Pt. 2), 1487-8, 1995).
Freeman, J. E. (Applied Spectroscopy 38(6), 837-43, 1984).
Duniotz, “Disappearing Polymorphs”, Acc. Chem. Res., vol. 28, pp. 193-200 (1995).
Gavezzotti, A., “Are Crystal Structures Predictable?”, Acc. Chem. Res. , vol. 27, pp. 309-314 (1994).
USP Dictionary of USAN and International Drug Names, p. 509 (lopinavir entry) (2001).
Ö. Almarsson et al.,Novel Approaches to Issues of Developability, Curr. Drug. Disc. Jan. 6-21, 2003.
J. Bernstein,Crystal Structure Prediction and Polymorphism, ACA Transactions 39:14-23 (2004).
J.D. Dunitz et al.,Disappearing Polymorphs, Acc. Chem. Res. 28(4):193-200 (1995).
J.D. Dunitz,Are Crystal Structures Predictable? Chem. Commun: 545-8 (2003).
A. Gavezzotti,Are Crystal Structures Predictable? Acc. Chem. Res. 27(10):309-14 (1994).
U.S. Appl. No. 09/538,257, Notice of Abandonment, Jul. 13, 2001.
U.S. Appl. No. 60/177,020, filed Jan. 19, 2000.
U.S. Patent Application Publication No. 2005/0124810, Office Action, Sep. 9, 2005.
U.S. Patent Application Publication No. 2005/0124810, Office Action, Apr. 17, 2006.
U.S. Patent Application Publication No. 2005/0124810, Notice of Abandonment, Nov. 22, 2006.
Chemburkar Sanjay
Dickman Daniel A.
Fort James J.
Henry Rodger F.
Lechuga-Ballesteros David
Abbott Laboratories
Davis Bradley E.
Lukton David
LandOfFree
Crystalline pharmaceutical does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline pharmaceutical, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline pharmaceutical will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4266389